The combination of the proteasome inhibitor bortezomib and the bcl-2 antisense molecule oblimersen sensitizes human B-cell lymphomas to cyclophosphamide (Q40283552)
Jump to navigation
Jump to search
scientific article published on May 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The combination of the proteasome inhibitor bortezomib and the bcl-2 antisense molecule oblimersen sensitizes human B-cell lymphomas to cyclophosphamide |
scientific article published on May 2006 |
Statements
1 reference
The combination of the proteasome inhibitor bortezomib and the bcl-2 antisense molecule oblimersen sensitizes human B-cell lymphomas to cyclophosphamide (English)
1 reference
Guido Marcucci
1 reference
Owen A O'Connor
1 reference
Emily A Smith
1 reference
Lorraine E Toner
1 reference
Julie Teruya-Feldstein
1 reference
Stanley Frankel
1 reference
Mark Rolfe
1 reference
Xiaohui Wei
1 reference
Shujun Liu
1 reference
Kenneth K Chan
1 reference
Asher Chanan-Khan
1 reference
1 May 2006
1 reference
1 reference
12
1 reference
9
1 reference
2902-2911
1 reference
Identifiers
1 reference
1 reference